BioSpace News Archive

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) today announced that it will present full data from the Phase 2 clinical trial evaluating setmelanotide in hypothalamic obesity during The Obesity Society’s ObesityWeek® 2022.

Catalyst Pharmaceuticals, Inc. announced that it will release its third quarter 2022 financial results after market close on Wednesday, November 9, 2022.

Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us”) today announced that Chief Executive Officer Ilya Rachman, MD, PhD, and Chief Financial Officer Gabriel Morris will present a company overview and milestones achieved to enable kick-off of 2 IMX-110 clinical trials at the ThinkEquity Conference at the Mandarin Oriental Hotel in New York, New York on Wednesday, October 26, 2022 at 2:00 PM ET.

SK bioscience today announced that the Company made a new partnership agreement with the Coalition for Epidemic Preparedness Innovations (CEPI) for the development of mRNA vaccines to quickly respond to the spread of infectious diseases and to expand its vaccine portfolio.

Thorne HealthTech, Inc. (“Thorne HealthTech” or “Thorne”) (NASDAQ: THRN) announced today that it is collaborating with GenTegra to utilize GenTegra’s patented Active Chemical Protection™ technology and Thorne’s OneDraw™ collection device to develop a whole blood DNA collection cartridge and a complete stabilization and extraction kit.

AtriCure, Inc., a leading innovator in surgical treatments for atrial fibrillation, left atrial appendage management, and post-operative pain management, announced that the company will be participating in upcoming investor conferences.

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and prevent infectious diseases, cancer, and diseases associated with HPV, announced today that third quarter 2022 financial results will be released after the market close on November 8, 2022 .

Resolve Biosciences, the pioneer in Molecular Cartography™ technology, today announced the appointment of Paul Steinberg as Chief Commercial Officer.

Koneksa, a healthcare technology company developing evidence-based validated digital biomarkers, today announced the launch of its clinical pipeline featuring biomarkers across neuroscience, oncology, respiratory, and other therapeutic areas.

Tenon Medical, Inc. today announced Institutional Review Board (“IRB”) approval from WCG IRB for two separate Tenon-sponsored post market clinical studies of the Company’s Catamaran SI Joint Fusion System (the “Catamaran”).